ZIMMER BIOMET: what changed
What changed
ZIMMER BIOMET
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€3.3m
2024 · €3.2m+€178,498
Equity
€37.0m
2024 · €33.6m+€3.3m
Cash
-
not filed
Balance sheet total
€60.0m
2024 · €44.1m+€15.9m
Largest movements
Assets
- Receivables within one year +€15.9m
up €15.9m (+38.5%), from €41.3m to €57.2m
of which Other amounts receivable: +€14.7m
Equity and liabilities
- Trade debts +€11.6m
up €11.6m (+238%), from €4.9m to €16.4m
- Profit (loss) carried forward +€3.3m
up €3.3m (+11.1%), from €30.2m to €33.5m
Income statement
- Turnover +€1.3m
up €1.3m (+1.7%), from €78.6m to €79.9m
- Goods and materials +€978,929
up €978,929 (+1.7%), from €59.0m to €60.0m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€3.2m
Turnover
+€1.3m
Other operating income
-€141,452
Goods and materials
-€978,929
Services and other goods
+€161,724
Staff costs
+€236,874
Depreciation
+€48,127
Other operating charges
-€111,744
Financial income
-€260,020
Financial charges
-€1,088
Taxes
-€121,400
Result 2025
€3.3m
raises the resultlowers the result
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,092,482 | €60,004,703 | +€15.9m | +36.1% |
| Fixed assets | 21/28 | €400,851 | €341,991 | -€58,861 | -14.7% |
| Tangible fixed assets | 22/27 | €325,519 | €275,471 | -€50,049 | -15.4% |
| Plant, machinery and equipment | 23 | €71,422 | €57,061 | -€14,361 | -20.1% |
| Furniture and vehicles | 24 | €2,159 | €1,651 | -€508 | -23.5% |
| Other tangible fixed assets | 26 | €251,938 | €216,758 | -€35,179 | -14.0% |
| Assets under construction and advance payments | 27 | €0 | - | = | |
| Financial fixed assets | 28 | €75,332 | €66,520 | -€8,812 | -11.7% |
| Other financial fixed assets | 284/8 | €75,332 | €66,520 | -€8,812 | -11.7% |
| Amounts receivable and cash guarantees | 285/8 | €75,332 | €66,520 | -€8,812 | -11.7% |
| Current assets | 29/58 | €43,691,630 | €59,662,712 | +€16.0m | +36.6% |
| Amounts receivable after more than one year | 29 | €2,249,317 | €2,358,198 | +€108,881 | +4.8% |
| Trade receivables | 290 | €2,249,317 | €2,358,198 | +€108,881 | +4.8% |
| Stocks and contracts in progress | 3 | €0 | €0 | = | |
| Amounts receivable within one year | 40/41 | €41,331,922 | €57,228,998 | +€15.9m | +38.5% |
| Trade receivables | 40 | €15,585,614 | €16,788,104 | +€1.2m | +7.7% |
| Other amounts receivable | 41 | €25,746,309 | €40,440,894 | +€14.7m | +57.1% |
| Deferred charges and accrued income | 490/1 | €110,391 | €75,516 | -€34,875 | -31.6% |
| Total equity and liabilities | 10/49 | €44,092,482 | €60,004,703 | +€15.9m | +36.1% |
| Equity | 10/15 | €33,640,597 | €36,986,082 | +€3.3m | +9.9% |
| Contributions | 10/11 | €784,121 | €784,121 | = | 0.0% |
| Reserves | 13 | €2,662,514 | €2,662,514 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €2,662,514 | €2,662,514 | = | 0.0% |
| Profit (loss) carried forward | 14 | €30,193,962 | €33,539,447 | +€3.3m | +11.1% |
| Amounts payable | 17/49 | €10,451,885 | €23,018,621 | +€12.6m | +120% |
| Amounts payable within one year | 42/48 | €8,509,704 | €20,639,116 | +€12.1m | +143% |
| Trade debts | 44 | €4,867,455 | €16,431,730 | +€11.6m | +238% |
| Suppliers | 440/4 | €4,867,455 | €16,431,730 | +€11.6m | +238% |
| Taxes, remuneration and social security | 45 | €3,642,250 | €4,207,386 | +€565,136 | +15.5% |
| Taxes | 450/3 | €493,012 | €861,243 | +€368,231 | +74.7% |
| Remuneration and social security | 454/9 | €3,149,237 | €3,346,143 | +€196,906 | +6.3% |
| Accrued charges and deferred income | 492/3 | €1,942,181 | €2,379,506 | +€437,325 | +22.5% |
| Operating income | 70/76A | €81,544,166 | €82,749,120 | +€1.2m | +1.5% |
| Turnover | 70 | €78,582,002 | €79,928,408 | +€1.3m | +1.7% |
| Other operating income | 74 | €2,962,164 | €2,820,712 | -€141,452 | -4.8% |
| Operating charges | 60/66A | €77,783,686 | €78,427,633 | +€643,948 | +0.8% |
| Goods for resale, raw materials and consumables | 60 | €58,975,444 | €59,954,374 | +€978,929 | +1.7% |
| Purchases | 600/8 | €58,975,444 | €59,954,374 | +€978,929 | +1.7% |
| Services and other goods | 61 | €4,725,779 | €4,564,055 | -€161,724 | -3.4% |
| Remuneration, social security and pensions | 62 | €13,850,453 | €13,613,579 | -€236,874 | -1.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €126,451 | €78,323 | -€48,127 | -38.1% |
| Other operating charges | 640/8 | €105,558 | €217,302 | +€111,744 | +106% |
| Operating profit (loss) | 9901 | €3,760,480 | €4,321,486 | +€561,006 | +14.9% |
| Financial income | 75/76B | €859,614 | €599,595 | -€260,020 | -30.2% |
| Recurring financial income | 75 | €859,614 | €599,595 | -€260,020 | -30.2% |
| Income from current assets | 751 | €859,545 | €584,950 | -€274,595 | -31.9% |
| Other financial income | 752/9 | €70 | €14,645 | +€14,575 | +20,927% |
| Financial charges | 65/66B | €6,687 | €7,774 | +€1,088 | +16.3% |
| Recurring financial charges | 65 | €6,687 | €7,774 | +€1,088 | +16.3% |
| Debt charges | 650 | - | €0 | +€0 | |
| Other financial charges | 652/9 | €6,687 | €7,774 | +€1,087 | +16.3% |
| Profit (loss) for the period before taxes | 9903 | €4,613,408 | €4,913,306 | +€299,899 | +6.5% |
| Income taxes | 67/77 | €1,446,421 | €1,567,821 | +€121,400 | +8.4% |
| Taxes | 670/3 | €1,446,421 | €1,660,531 | +€214,110 | +14.8% |
| Tax adjustments and reversals of tax provisions | 77 | - | €92,710 | +€92,710 | |
| Profit (loss) for the period | 9904 | €3,166,987 | €3,345,485 | +€178,498 | +5.6% |
| Profit (loss) for the period to be appropriated | 9905 | €3,166,987 | €3,345,485 | +€178,498 | +5.6% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.